Published Dec 12, 2023
Big Ideas in 2024: Programming Medicine’s Final Frontier with Jorge Conde
Explore the transformative potential of programmable medicines as Jorge Conde, General Partner at a16z, delves into the rapid advancements in gene editing technologies and the FDA's evolving regulatory approach, comparing these innovations to the impact of reusable rockets on space travel.
